Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design — HOME Study report number 1-Reference-Cited by-同舟云学术

Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design — HOME Study report number 1

Published:2014-03 Issue:2 Volume:37 Page:294-300
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Chew Emily Y.^ORCID,Clemons Traci E.,Bressler Susan B.,Elman Michael J.,Danis Ronald P.,Domalpally Amitha^ORCID,Heier Jeffrey S.^ORCID,Kim Judy E.,Garfinkel Richard A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference19 articles.

1. Causes and prevalence of visual impairment among adults in the United States;Congdon;Arch Ophthalmol,2004

2. Prevalence of age-related macular degeneration in the United States;Friedman;Arch Ophthalmol,2004

3. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies;Pascolini;Ophthalmic Epidemiol,2004

5. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Home-monitoring for neovascular age-related macular degeneration in older adults within the UK: the MONARCH diagnostic accuracy study;HEALTH TECHNOL ASSES;2024

2. More Homework for Patients With Macular Degeneration?;JAMA Ophthalmology;2024-06-01

3. An Updated Simplified Severity Scale for Age-Related Macular Degeneration Incorporating Reticular Pseudodrusen;Ophthalmology;2024-04

4. Tablet‐based tests of everyday visual function in a diabetic macular oedema (DME) clinic waiting area: A feasibility study;Ophthalmic and Physiological Optics;2023-12-22

5. Teleophthalmology and retina: a review of current tools, pathways and services;International Journal of Retina and Vitreous;2023-12-05